These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36447388)

  • 1. KID: A Kinase-Focused Interaction Database and Its Application in the Construction of Kinase-Focused Molecule Databases.
    Dai X; Xu Y; Qiu H; Qian X; Lin M; Luo L; Zhao Y; Huang D; Zhang Y; Chen Y; Liu H; Jiang Y
    J Chem Inf Model; 2022 Dec; 62(23):6022-6034. PubMed ID: 36447388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Silico Design and Analysis of a Kinase-Focused Combinatorial Library Considering Diversity and Quality.
    Yang Y; Zhang Y; Hua Y; Chen X; Fan Y; Wang Y; Liang L; Deng C; Lu T; Chen Y; Liu H
    J Chem Inf Model; 2020 Jan; 60(1):92-107. PubMed ID: 31886658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scaffold mining of kinase hinge binders in crystal structure database.
    Xing L; Rai B; Lunney EA
    J Comput Aided Mol Des; 2014 Jan; 28(1):13-23. PubMed ID: 24375079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinase hinge binding scaffolds and their hydrogen bond patterns.
    Xing L; Klug-Mcleod J; Rai B; Lunney EA
    Bioorg Med Chem; 2015 Oct; 23(19):6520-7. PubMed ID: 26358279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.
    Deng Z; Chuaqui C; Singh J
    J Med Chem; 2004 Jan; 47(2):337-44. PubMed ID: 14711306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current kinase inhibitors cover a tiny fraction of fragment space.
    Zhao H; Caflisch A
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2372-6. PubMed ID: 25911301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KLIFS: a knowledge-based structural database to navigate kinase-ligand interaction space.
    van Linden OP; Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
    J Med Chem; 2014 Jan; 57(2):249-77. PubMed ID: 23941661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatic Rings as Molecular Determinants for the Molecular Recognition of Protein Kinase Inhibitors.
    Zhu Y; Alqahtani S; Hu X
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33810025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo design of protein kinase inhibitors by in silico identification of hinge region-binding fragments.
    Urich R; Wishart G; Kiczun M; Richters A; Tidten-Luksch N; Rauh D; Sherborne B; Wyatt PG; Brenk R
    ACS Chem Biol; 2013 May; 8(5):1044-52. PubMed ID: 23534475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KinFragLib: Exploring the Kinase Inhibitor Space Using Subpocket-Focused Fragmentation and Recombination.
    Sydow D; Schmiel P; Mortier J; Volkamer A
    J Chem Inf Model; 2020 Dec; 60(12):6081-6094. PubMed ID: 33155465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ProfKin: A comprehensive web server for structure-based kinase profiling.
    Shen Z; Yan YH; Yang S; Zhu S; Yuan Y; Qiu Z; Jia H; Wang R; Li GB; Li H
    Eur J Med Chem; 2021 Dec; 225():113772. PubMed ID: 34411891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinase Crystal Miner: A Powerful Approach to Repurposing 3D Hinge Binding Fragments and Its Application to Finding Novel Bruton Tyrosine Kinase Inhibitors.
    Mukherjee P; Bentzien J; Bosanac T; Mao W; Burke M; Muegge I
    J Chem Inf Model; 2017 Sep; 57(9):2152-2160. PubMed ID: 28792217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIDFamMap: a database of kinase-inhibitor-disease family maps for kinase inhibitor selectivity and binding mechanisms.
    Chiu YY; Lin CT; Huang JW; Hsu KC; Tseng JH; You SR; Yang JM
    Nucleic Acids Res; 2013 Jan; 41(Database issue):D430-40. PubMed ID: 23193279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacophore map of small molecule protein kinase inhibitors.
    McGregor MJ
    J Chem Inf Model; 2007; 47(6):2374-82. PubMed ID: 17941626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting kinase profiling data to predict activity and understand cross-reactivity of kinase inhibitors.
    Niijima S; Shiraishi A; Okuno Y
    J Chem Inf Model; 2012 Apr; 52(4):901-12. PubMed ID: 22414491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-guided expansion of kinase fragment libraries driven by support vector machine models.
    Erickson JA; Mader MM; Watson IA; Webster YW; Higgs RE; Bell MA; Vieth M
    Biochim Biophys Acta; 2010 Mar; 1804(3):642-52. PubMed ID: 20005305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragment-based approaches to the discovery of kinase inhibitors.
    Mortenson PN; Berdini V; O'Reilly M
    Methods Enzymol; 2014; 548():69-92. PubMed ID: 25399642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PADFrag: A Database Built for the Exploration of Bioactive Fragment Space for Drug Discovery.
    Yang JF; Wang F; Jiang W; Zhou GY; Li CZ; Zhu XL; Hao GF; Yang GF
    J Chem Inf Model; 2018 Sep; 58(9):1725-1730. PubMed ID: 30134653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase-inhibitor database: structural variability of and inhibitor interactions with the protein kinase P-loop.
    Patel RY; Doerksen RJ
    J Proteome Res; 2010 Sep; 9(9):4433-42. PubMed ID: 20681595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinase-likeness and kinase-privileged fragments: toward virtual polypharmacology.
    Aronov AM; McClain B; Moody CS; Murcko MA
    J Med Chem; 2008 Mar; 51(5):1214-22. PubMed ID: 18288794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.